Pharma-Bio Serv, Inc. (PBSV) stock
PBSVOTCServices-Management Consulting ServicesFiscal year ends October 31
$0.48+0.08 (+20.00%)
Close on Oct 19, 2026Market cap $11.00MP/E 48.0Yield –
Pharma-Bio Serv cash
Cash and short-term investments held at the end of each period.
Pharma-Bio Serv's cash was $8.58M at Jul 31, 2026. For fiscal 2025 it was $10.85M, down 14.8% from the year before. Over ten years it grew -3.1% a year on average. The highest annual figure on record is $17.47M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $10.85M | -14.8% |
| FY2024 | Oct 31, 2024 | $12.75M | -14.9% |
| FY2023 | Oct 31, 2023 | $14.98M | +3.6% |
| FY2022 | Oct 31, 2022 | $14.46M | -17.2% |
| FY2021 | Oct 31, 2021 | $17.47M | +1.9% |
| FY2020 | Oct 31, 2020 | $17.14M | +10.6% |
| FY2019 | Oct 31, 2019 | $15.49M | -3.6% |
| FY2018 | Oct 31, 2018 | $16.07M | +38.4% |
| FY2017 | Oct 31, 2017 | $11.62M | -15.8% |
| FY2016 | Oct 31, 2016 | $13.79M | -7.6% |
| FY2015 | Oct 31, 2015 | $14.93M | -1.5% |
| FY2014 | Oct 31, 2014 | $15.16M | +25.1% |
| FY2013 | Oct 31, 2013 | $12.12M | +82.7% |
| FY2012 | Oct 31, 2012 | $6.63M | +50.4% |
| FY2011 | Oct 31, 2011 | $4.41M | +82.9% |
| FY2010 | Oct 31, 2010 | $2.41M | +17.6% |
| FY2009 | Oct 31, 2009 | $2.05M | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jul 31, 2026 | $8.58M | -20.0% |
| Q2 FY2026CQ1 2026 | Apr 30, 2026 | $8.47M | -18.6% |
| Q1 FY2026CQ4 2025 | Jan 31, 2026 | $10.56M | -15.1% |
| Q4 FY2025CQ3 2025 | Oct 31, 2025 | $10.85M | -14.8% |
| Q3 FY2025CQ2 2025 | Jul 31, 2025 | $10.73M | -16.6% |
| Q2 FY2025CQ1 2025 | Apr 30, 2025 | $10.41M | -22.7% |
| Q1 FY2025CQ4 2024 | Jan 31, 2025 | $12.43M | -21.7% |
| Q4 FY2024CQ3 2024 | Oct 31, 2024 | $12.75M | -14.9% |
| Q3 FY2024CQ2 2024 | Jul 31, 2024 | $12.86M | -11.8% |
| Q2 FY2024CQ1 2024 | Apr 30, 2024 | $13.47M | -1.0% |
| Q1 FY2024CQ4 2023 | Jan 31, 2024 | $15.89M | +2.7% |
| Q4 FY2023CQ3 2023 | Oct 31, 2023 | $14.98M | +3.6% |
| Q3 FY2023CQ2 2023 | Jul 31, 2023 | $14.58M | +2.4% |
| Q2 FY2023CQ1 2023 | Apr 30, 2023 | $13.60M | +3.3% |
| Q1 FY2023CQ4 2022 | Jan 31, 2023 | $15.47M | -11.4% |
| Q4 FY2022CQ3 2022 | Oct 31, 2022 | $14.46M | -12.3% |
| Q1 FY2022CQ4 2021 | Jul 31, 2022 | $14.24M | -11.4% |
| Q2 FY2022CQ1 2022 | Apr 30, 2022 | $13.16M | -30.7% |
| Q4 FY2021CQ3 2021 | Oct 31, 2021 | $17.47M | +1.9% |
| Q3 FY2021CQ2 2021 | Jul 31, 2021 | $16.50M | -1.9% |
| Q2 FY2021CQ1 2021 | Apr 30, 2021 | $16.07M | +3.1% |
| Q1 FY2021CQ4 2020 | Jan 31, 2021 | $18.99M | +24.5% |
| Q4 FY2020CQ3 2020 | Oct 31, 2020 | $17.14M | +10.6% |
| Q3 FY2020CQ2 2020 | Jul 31, 2020 | $16.81M | +13.6% |
| Q2 FY2020CQ1 2020 | Apr 30, 2020 | $15.58M | +1.0% |
| Q1 FY2020CQ4 2019 | Jan 31, 2020 | $15.25M | -3.4% |
| Q4 FY2019CQ3 2019 | Oct 31, 2019 | $15.49M | -3.6% |
| Q3 FY2019CQ2 2019 | Jul 31, 2019 | $14.80M | -2.4% |
| Q2 FY2019CQ1 2019 | Apr 30, 2019 | $15.43M | +19.1% |
| Q1 FY2019CQ4 2018 | Jan 31, 2019 | $15.80M | +20.6% |
| Q4 FY2018CQ3 2018 | Oct 31, 2018 | $16.07M | +38.4% |
| Q3 FY2018CQ2 2018 | Jul 31, 2018 | $15.16M | +23.9% |
| Q2 FY2018CQ1 2018 | Apr 30, 2018 | $12.95M | +1.8% |
| Q1 FY2018CQ4 2017 | Jan 31, 2018 | $13.10M | -4.3% |
| Q4 FY2017CQ3 2017 | Oct 31, 2017 | $11.62M | -15.8% |
| Q3 FY2017CQ2 2017 | Jul 31, 2017 | $12.23M | -12.9% |
| Q2 FY2017CQ1 2017 | Apr 30, 2017 | $12.73M | – |
| Q1 FY2017CQ4 2016 | Jan 31, 2017 | $13.69M | – |
| Q4 FY2016CQ3 2016 | Oct 31, 2016 | $13.79M | – |
| Q3 FY2016CQ2 2016 | Jul 31, 2016 | $14.04M | – |
See a number that looks wrong?